GH Research PLC 1KA.F Stock
GH Research PLC Price Chart
GH Research PLC 1KA.F Financial and Trading Overview
| GH Research PLC stock price | 10.2 EUR |
| Previous Close | 10 EUR |
| Open | 10.3 EUR |
| Bid | 10.3 EUR x N/A |
| Ask | 11.8 EUR x N/A |
| Day's Range | 10.3 - 10.3 EUR |
| 52 Week Range | 4.76 - 15.8 EUR |
| Volume | 10 EUR |
| Avg. Volume | 1 EUR |
| Market Cap | 535.81M EUR |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.63 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 32.33 EUR |
1KA.F Valuation Measures
| Enterprise Value | 358.51M EUR |
| Trailing P/E | N/A |
| Forward P/E | -12.716049 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 2.2155302 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -10.847 |
Trading Information
GH Research PLC Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 18.71% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 15.8 EUR |
| 52 Week Low | 4.76 EUR |
| 50-Day Moving Average | 8.19 EUR |
| 200-Day Moving Average | 9.41 EUR |
1KA.F Share Statistics
| Avg. Volume (3 month) | 1 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 52.02M |
| Float | 12.42M |
| Short Ratio | N/A |
| % Held by Insiders | 40.39% |
| % Held by Institutions | 61.38% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -7.92% |
| Return on Equity (ttm) | -10.80% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -33053000 EUR |
| Net Income Avi to Common (ttm) | -27630000 EUR |
| Diluted EPS (ttm) | -0.52 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 162.82M EUR |
| Total Cash Per Share (mrq) | 3.13 EUR |
| Total Debt (mrq) | 1.13M EUR |
| Total Debt/Equity (mrq) | 0.47 EUR |
| Current Ratio (mrq) | 24.814 |
| Book Value Per Share (mrq) | 4.649 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -27083000 EUR |
| Levered Free Cash Flow (ttm) | -15899500 EUR |
Profile of GH Research PLC
| Country | Germany |
| State | N/A |
| City | Dublin |
| Address | Joshua Dawson House |
| ZIP | D02 RY95 |
| Phone | 353 1 437 8334 |
| Website | https://www.ghres.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 32 |
GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies to treat psychiatric and neurological disorders. The company develops 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH001, an inhalable mebufotenin product candidate that has completed two Phase 1 clinical trials and Phase 1/2 clinical trial in patients with TRD. The company also develops GH002, an intravenous mebufotenin product candidate; and GH003, an intranasal mebufotenin product candidate, which are in preclinical development trials with a focus on psychiatric and neurological disorders. GH Research PLC was incorporated in 2018 and is based in Dublin, Ireland.
Q&A For GH Research PLC Stock
What is a current 1KA.F stock price?
GH Research PLC 1KA.F stock price today per share is 10.2 EUR.
How to purchase GH Research PLC stock?
You can buy 1KA.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for GH Research PLC?
The stock symbol or ticker of GH Research PLC is 1KA.F.
Which industry does the GH Research PLC company belong to?
The GH Research PLC industry is Biotechnology.
How many shares does GH Research PLC have in circulation?
The max supply of GH Research PLC shares is 53.21M.
What is GH Research PLC Price to Earnings Ratio (PE Ratio)?
GH Research PLC PE Ratio is now.
What was GH Research PLC earnings per share over the trailing 12 months (TTM)?
GH Research PLC EPS is -0.63 EUR over the trailing 12 months.
Which sector does the GH Research PLC company belong to?
The GH Research PLC sector is Healthcare.